Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Duployez

Showing results (11-20 of 141) with videos related to

Pageof 15
Sort By:
American Journal of Hematology|January 7, 2020
When leukocytes bite off more than they can chewDoriane Dechaux-Blanc, Farid Zerimech, Anne-Sophie Guemann, et al.
British Journal of Haematology|August 19, 2021
Chronic myeloid leukaemia presenting with monocytosisBenjamin Podvin, Laure Goursaud, Pauline Roynard, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Acute Myeloid Leukemia: The Good, the Bad, and the UglyAndrew Kuykendall, Nicolas Duployez, Nicolas Boissel, et al.
International Journal of Laboratory Hematology|April 21, 2024
Oligomonocytic chronic myelomonocytic leukemia is eligible to MDS-score and not Mono-dysplasia scoreBenjamin Podvin, Marion Magierowicz, Valérie Soenen, et al.
British Journal of Haematology|May 23, 2022
Acute myeloid leukaemia with double minute chromosomes encompassing the 8q24 regionBenjamin Podvin, Hélène Guermouche, Elise Fournier, et al.
Haematologica|February 15, 2024
Postnatal origin of the chromosomal gains in older patients with high hyperdiploid acute lymphoblastic leukemiaMinjun Yang, Rebeqa Gunnarsson, Nicolas Duployez, et al.
Expert Opinion on Therapeutic Targets|April 28, 2021
Targeting RUNX1 in acute myeloid leukemia: preclinical innovations and therapeutic implicationsFanny Gonzales, Adeline Barthélémy, Pauline Peyrouze, et al.
Transfusion|November 20, 2025
Abnormal RH antigen expression in myeloid malignancies with MPL mutation, CSF3R mutation, or 1p deletion: Evidence of two distinct mechanismsRémi Bourgeois, Laure Delanoe, Gauthier Alluin, et al.
Haematologica|June 16, 2018
A novel type of <i>NPM1</i> mutation characterized by multiple internal tandem repeats in a case of cytogenetically normal acute myeloid leukemiaNicolas Duployez, Lydia Chebrek, Nathalie Helevaut, et al.
Bulletin Du Cancer|October 28, 2022
[Management of genetic predisposition to hematologic malignancies in patients undergoing allogeneic hematopoietic cell transplantation (HCT): Guidelines from the SFGM-TC]Valérie Coiteux, Laurène Fenwarth, Nicolas Duployez, et al.
Pageof 15

Showing results (11-20 of 141) with videos related to

Sort By:
Pageof 15
American Journal of Hematology|January 7, 2020
When leukocytes bite off more than they can chewDoriane Dechaux-Blanc, Farid Zerimech, Anne-Sophie Guemann, et al.
British Journal of Haematology|August 19, 2021
Chronic myeloid leukaemia presenting with monocytosisBenjamin Podvin, Laure Goursaud, Pauline Roynard, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Acute Myeloid Leukemia: The Good, the Bad, and the UglyAndrew Kuykendall, Nicolas Duployez, Nicolas Boissel, et al.
International Journal of Laboratory Hematology|April 21, 2024
Oligomonocytic chronic myelomonocytic leukemia is eligible to MDS-score and not Mono-dysplasia scoreBenjamin Podvin, Marion Magierowicz, Valérie Soenen, et al.
British Journal of Haematology|May 23, 2022
Acute myeloid leukaemia with double minute chromosomes encompassing the 8q24 regionBenjamin Podvin, Hélène Guermouche, Elise Fournier, et al.
Haematologica|February 15, 2024
Postnatal origin of the chromosomal gains in older patients with high hyperdiploid acute lymphoblastic leukemiaMinjun Yang, Rebeqa Gunnarsson, Nicolas Duployez, et al.
Expert Opinion on Therapeutic Targets|April 28, 2021
Targeting RUNX1 in acute myeloid leukemia: preclinical innovations and therapeutic implicationsFanny Gonzales, Adeline Barthélémy, Pauline Peyrouze, et al.
Transfusion|November 20, 2025
Abnormal RH antigen expression in myeloid malignancies with MPL mutation, CSF3R mutation, or 1p deletion: Evidence of two distinct mechanismsRémi Bourgeois, Laure Delanoe, Gauthier Alluin, et al.
Haematologica|June 16, 2018
A novel type of <i>NPM1</i> mutation characterized by multiple internal tandem repeats in a case of cytogenetically normal acute myeloid leukemiaNicolas Duployez, Lydia Chebrek, Nathalie Helevaut, et al.
Bulletin Du Cancer|October 28, 2022
[Management of genetic predisposition to hematologic malignancies in patients undergoing allogeneic hematopoietic cell transplantation (HCT): Guidelines from the SFGM-TC]Valérie Coiteux, Laurène Fenwarth, Nicolas Duployez, et al.
Pageof 15